ReviewThe journal of headache and pain2025
The vessel-to-neuron trigeminovascular hypothesis of migraine pathogenesis - the 'pro' argument.
Review in The journal of headache and pain, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The emerging role of the meningeal lymphatic and glymphatic systems in migraine pathophysiology: a systematic review.The journal of headache and pain · 2026Pooled it
- Calcitonin gene-related peptide induces headache attacks in people with idiopathic intracranial hypertension.Brain : a journal of neurology · 2026Trial
- Mechanisms of Acupuncture on the Neurovascular Unit in Migraine: A Narrative Review.European journal of neurology · 2026Review
- Pediatric migraine: Neurodevelopmental mechanisms, clinical phenotypes, and modern therapeutics.World journal of clinical pediatrics · 2026Review
- Sex-dependent central amygdala physiology after supradural CGRP exposure is associated with migraine-like behaviors.The journal of headache and pain · 2026Article
- Oxidative Stress in Migraine-Effect or Cause?Genes · 2026Review
- Post-pipeline headache after flow-diverting stenting for unruptured intracranial aneurysms: clinical, radiological findings, and proposed scoring system.Journal of neurology · 2026Article
- Glymphatic function restored by α1-noradrenergic antagonism alleviates headache allodynia in mice.bioRxiv : the preprint server for biology · 2026Article
- Gut microbiota dysbiosis and metabolic reprogramming in pediatric migraine: a multi-omics analysis revealing diagnostic biomarkers.The journal of headache and pain · 2026Article
- Integrative Migraine Therapy: From Current Concepts to Future Directions-A Plastic Surgeon's Perspective.Medicina (Kaunas, Lithuania) · 2025Review
- State-dependent facial pulsation asymmetry and phase asynchrony measured by imaging photoplethysmography and their coupling with contingent negative variation in migraine.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe pathogenesis of migraine remains incompletely understood, with traditional theories oscillating between purely vascular or strictly neuronal concepts. However, emerging evidence points to a more integrated "vessel-to-neuron" mechanism. This debate paper explores the role of intracranial vasculature in initiating migraine pain, offering a unifying concept that reconciles these traditionally divergent views.
findingsNeurosurgical findings confirm that stimulating or mechanically distending intracranial arteries can elicit migraine-like pain, suggesting that these vessels might serve as substrates for migraine pathogenesis. Activation of the trigeminovascular system and subsequent release of migraine-inducing neuropeptides lead to neurogenic inflammation within the meninges, promoting both vasodilation and the sensitization of meningeal nociceptors. Interestingly, all identified molecular migraine triggers potently dilate the intracranial vasculature, converging on potassium efflux from vascular smooth muscle cells. This efflux likely modifies local chemical gradients, thereby depolarizing trigeminal afferents and driving the cascade of ascending nociceptive signaling. Therapeutic interventions further reinforce the causal role of vascular contributions to migraine pathogenesis. Blocking vasodilatory neuropeptides or constricting extracerebral arteries effectively prevents and terminates migraine attacks, underscoring the importance of peripheral mechanisms. More than mere vasodilation, this hypothesis posits that chemical agents, including potassium released by vascular smooth muscle cells, might precipitate migraine onset. The resulting mechano-chemical stimulus might activate perivascular nociceptors and ascending trigeminal pain signaling, ultimately culminating in generation of a migraine attack.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.